Get the Stockscreener App
15.31
0.79%
0.12
After Hours:
15.31
Upstream Bio Inc stock is traded at $15.31, with a volume of 568.00K.
It is up +0.79% in the last 24 hours and up +39.44% over the past month.
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
See More
Previous Close:
$15.19
Open:
$15.25
24h Volume:
568.00K
Relative Volume:
1.32
Market Cap:
$823.58M
Revenue:
$2.22M
Net Income/Loss:
$-40.51M
P/E Ratio:
-11.92
EPS:
-1.2847
Net Cash Flow:
$-46.53M
1W Performance:
+14.68%
1M Performance:
+39.44%
6M Performance:
+42.15%
1Y Performance:
+0.00%
1-Day Range:
$15.02
$16.15
1-Week Range:
$12.74
$16.15
52-Week Range:
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
Name
Upstream Bio Inc
Sector
Industry
Phone
781-208-2466
Address
890 WINTER STREET, SUITE 200, WALTHAM
Compare UPB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
15.31 | 817.13M | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | Piper Sandler | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
Upstream Bio Inc Stock (UPB) Latest News
Does Upstream Bio Inc. stock perform well during market downturnsBest Dividend Picks For 2025 - jammulinksnews.com
Should I hold or sell Upstream Bio Inc. stock in 2025AI Powered Tips For Every Investor - jammulinksnews.com
Real time social sentiment graph for Upstream Bio Inc.AI-Powered Stock Trend Movement Analysis - Newser
Can swing trading help recover from Upstream Bio Inc. lossesWeekly Trend Screener with Momentum Picks - Newser
Is it too late to sell Upstream Bio Inc.Free Fast Exit and Entry Strategy Guide - Newser
How to manage a losing position in Upstream Bio Inc.Strategy Chart for Real-Time Trade Flow - Newser
What makes Upstream Bio Inc. stock price move sharplyFree Pattern Detection for Entry Confirmation - Newser
Exit strategy if you’re trapped in Upstream Bio Inc.AI Trend Detection for Entry Timing - Newser
When is Upstream Bio Inc. stock expected to show significant growthReal Time Tracker With High Returns - jammulinksnews.com
Positive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment - TipRanks
Promising Outlook for Upstream Bio, Inc. as Verekitug Advances in Inflammatory Conditions - TipRanks
Upstream Bio Inc. Shows Support at Fibonacci LevelCommunity Shared Smart Money Signals Show Movement - metal.it
JPMorgan reiterates Overweight rating on Upstream Bio stock ahead of trial data - Investing.com Canada
Real time social sentiment graph for Upstream Bio Inc. Chart Scanner for Swing Trade Timing - Newser
New York State Common Retirement Fund Invests $29,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
What are Upstream Bio Inc. company’s key revenue driversMaximize your returns with portfolio optimization - jammulinksnews.com
What is the risk reward ratio of investing in Upstream Bio Inc. stockGet professional guidance for market timing - jammulinksnews.com
How Upstream Bio Inc. stock performs during market volatilityAlpha Stock Ideas - Newser
We Think Upstream Bio (NASDAQ:UPB) Can Afford To Drive Business Growth - 富途牛牛
Upstream Bio Inc (UPB) Stock: A Year of Highs and Lows - investchronicle.com
What drives Upstream Bio Inc. stock priceOutstanding trading profits - jammulinksnews.com
Upstream Bio Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
What analysts say about Upstream Bio Inc. stockOutstanding capital returns - jammulinksnews.com
Is Upstream Bio Inc. a good long term investmentConsistent high-yield stocks - jammulinksnews.com
J.P. Morgan Maintains UpStream Bio(UPB.US) With Buy Rating - 富途牛牛
how upstream bio inc. stock performs during market volatilityFree Stock Market Insider Analysis - Newser
Upstream Bio, Inc. shares fall 4.98% premarket after HBM Healthcare Investments reports an 8.4% decline in NAV per share. - AInvest
What risks could impact Upstream Bio Inc. stock performanceHigh Potential Shares - Newser
Why Upstream Bio Inc. stock attracts strong analyst attentionHigh Return Conservative Stocks - Newser
Upstream Bio Inc Stock (UPB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):